Lingfan Xu

Years Active: 2021-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Lingfan Xu, Bing Zhao, William Butler, Huan Xu, Nan Song, Xufeng Chen, J Spencer Hauck, Xia Gao, Hong Zhang, Jeff Groth, Qing Yang, Yue Zhao, David Moon, Daniel George, Yinglu Zhou, Yiping He, Jiaoti Huang
Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer. Oncogene 41 (8) (2022)
Lingfan Xu, Yu Yin, Yanjing Li, Xu-Feng Chen, Yan Chang, Hong Zhang, Juan Liu, James Beasley, Patricia McCaw, Haoyue Zhang, Sarah P Young, Jeff Groth, Qianben Wang, Jason W Locasale, Xia Gao, Dean G Tang, Xuesen Dong, Yiping He, Daniel George, Hailiang Hu, Jiaoti Huang
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 118 (13) (2021)
Brendon M Patierno, Wen-Chi Foo, Tyler Allen, Jason A Somarelli, Kathryn E Ware, Santosh Gupta, Sandra Wise, John P Wise, Xiaodi Qin, Dadong Zhang, Lingfan Xu, Yanjing Li, Xufeng Chen, Brant A Inman, Shannon J McCall, Jiaoti Huang, Rick A Kittles, Kouros Owzar, Simon Gregory, Andrew J Armstrong, Daniel J George, Steven R Patierno, David S Hsu, Jennifer A Freedman
Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry. Prostate cancer and prostatic diseases (2021)

Lingfan Xu.css-eqlu8i{font-size:small;padding-left:4px;}